Betamethasone Topical Foam 0.12pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Betamethasone: Topical foam (0.12%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Betamethasone Val 0.12% Foam
Drug Image file default-drug-image.png
Betamethasone Val 0.12% Foam

What is this Medicine?

BETAMETHASONE (bay ta METH a sone) is a corticosteroid. It is used to treat scaling, redness, and itching due to scalp problems such as scalp psoriasis.

Similar Brand Name Drugs : Luxiq Foam: Topical foam (0.12%)
CVS Pharmacy Patient Statistics for Betamethasone: Topical foam(0.12%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Betamethasone Valerate 0.12% Topical Foam

NDC: 458020053
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Contact Dermatitis, Keloids, Mycosis Fungoides, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Cutaneous T-cell Lymphoma (CTCL), Discoid Lupus Erythematosus, Granuloma Annulare, Dermatitis Herpetiformis, Seborrheic Dermatitis, Pruritus, Pityriasis Rosea, Psoriasis, Lichen Simplex, Stevens-Johnson Syndrome, Atopic Dermatitis, Lichen Planus, Exfoliative Dermatitis

Storage Information
Flammable, keep away from heat and flame
Do Not Store at Temperatures Above 120 degrees F (49 degrees C)
Store at controlled room temperature (between 68 and 77 degrees F)
Betamethasone Valerate 0.12% Topical Foam

Reported Side Effects for Betamethasone Valerate 0.12% Topical Foam

Thinning Of Skin Incidence:
<33.0%*
Severity: SEVERE
Onset: DELAYED
Hypothalamic-pituitary-adrenal (HPA) Suppression Incidence:
<73.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Betamethasone

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.